<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>TODO • ClinicoPath</title><script src="deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="deps/headroom-0.11.0/headroom.min.js"></script><script src="deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="deps/search-1.0.0/fuse.min.js"></script><script src="deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="pkgdown.js"></script><meta property="og:title" content="TODO"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="index.html">ClinicoPath</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.3.91</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item"><a class="nav-link" href="dev/index.html"><span class="fa fa-cogs"></span></a></li>
<li class="nav-item"><a class="nav-link" href="reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="articles/clinical-workflow.html">Clinical Research Workflow with ClinicoPathDescriptives</a></li>
    <li><a class="dropdown-item" href="articles/module-development-jamovi.html">ClinicoPath Module Development Guide</a></li>
    <li><a class="dropdown-item" href="articles/pathology-jamovi.html">Using jamovi for the Common Statistical Analysis in Pathology</a></li>
    <li><a class="dropdown-item" href="articles/pkgnet-report.html">ClinicoPath Package Report, by pkgnet</a></li>
    <li><a class="dropdown-item" href="articles/users-of-ClinicoPath.html">Users of ClinicoPath</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><a class="external-link nav-link" href="http://twitter.com/serdarbalci"><span class="fa fab fa-twitter fa-lg"></span></a></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/sbalci/ClinicoPathJamoviModule/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-title-body">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>TODO</h1>
      <small class="dont-index">Source: <a href="https://github.com/sbalci/ClinicoPathJamoviModule/blob/HEAD/TODO.md" class="external-link"><code>TODO.md</code></a></small>
    </div>


<div id="todo" class="section level1">

</div>
<div class="section level1">
<h1 id="stage-migration-module---future-enhancements">Stage Migration Module - Future Enhancements<a class="anchor" aria-label="anchor" href="#stage-migration-module---future-enhancements"></a></h1>
<div class="section level2">
<h2 id="summary">Summary<a class="anchor" aria-label="anchor" href="#summary"></a></h2>
<p>The stagemigration module has completed <strong>Phase 1</strong> (Foundational Features), <strong>Phase 2</strong> (Advanced Validation &amp; Clinical Utility), <strong>Phase 3</strong> (Clinical Integration Features), and major components of <strong>Phase 4-5</strong> (Advanced Features - Enhanced Statistical Analysis Suite).</p>
<p><strong>Completed Advanced Features (v0.0.3.72-v0.0.3.81):</strong></p>
<ul><li>✅ Optimal Cut-point Determination (v0.0.3.72)</li>
<li>✅ SHAP Model Interpretability (v0.0.3.73)<br></li>
<li>✅ Competing Risks Analysis with Fine-Gray Models (v0.0.3.74)</li>
<li>✅ Multi-State Models (v0.0.3.75)</li>
<li>✅ Random Survival Forests (v0.0.3.76)</li>
<li>✅ Cure Models (v0.0.3.77)</li>
<li>✅ Interval Censoring Support (v0.0.3.78)</li>
<li>✅ Informative Censoring Detection (v0.0.3.79)</li>
<li>✅ Concordance Probability Estimates (v0.0.3.80)</li>
<li>✅ Win Ratio Analysis (v0.0.3.80)</li>
<li>✅ Frailty Models for Clustering (v0.0.3.81)</li>
</ul><p>This document lists the <strong>remaining features</strong> that could further enhance the module for research and specialized use cases.</p>
<hr></div>
<div class="section level2">
<h2 id="phase-4-enhanced-features-from-chatgpt-stage-migration-analysis"><strong>Phase 4: Enhanced Features from ChatGPT Stage Migration Analysis</strong><a class="anchor" aria-label="anchor" href="#phase-4-enhanced-features-from-chatgpt-stage-migration-analysis"></a></h2>
<div class="section level3">
<h3 id="id_1-advanced-will-rogers-phenomenon-analysis"><strong>1. Advanced Will Rogers Phenomenon Analysis</strong><a class="anchor" aria-label="anchor" href="#id_1-advanced-will-rogers-phenomenon-analysis"></a></h3>
<ul><li>
<strong>Temporal Comparison Framework:</strong> Compare stage-specific survival across different time periods to detect artifacts vs. real improvements</li>
</ul></div>
<div class="section level3">
<h3 id="id_2-real-world-clinical-examples-integration"><strong>2. Real-World Clinical Examples Integration</strong><a class="anchor" aria-label="anchor" href="#id_2-real-world-clinical-examples-integration"></a></h3>
<ul><li>
<strong>Cancer-Specific Templates:</strong>
<ul><li>Pancreatic cancer AJCC 8th edition validation templates</li>
<li>Colorectal cancer lymph node examination effects</li>
<li>Thyroid cancer age threshold migration analysis</li>
<li>Lung cancer imaging advancement effects</li>
</ul></li>
<li>
<strong>Era Comparison Tools:</strong> Temporal analysis accounting for diagnostic advancement bias</li>
<li>
<strong>Morphologic Feature Integration:</strong> Tools for adding new prognostic factors (size, invasion patterns, etc.)</li>
</ul></div>
<div class="section level3">
<h3 id="id_3-methodological-validation-framework"><strong>3. Methodological Validation Framework</strong><a class="anchor" aria-label="anchor" href="#id_3-methodological-validation-framework"></a></h3>
<ul><li>
<strong>External Validation Tools:</strong> Framework for validating staging systems on independent cohorts</li>
<li>
<strong>Sensitivity Analysis:</strong> Robust analysis under different assumptions and scenarios</li>
</ul></div>
<div class="section level3">
<h3 id="id_4-clinical-decision-support-enhancements"><strong>4. Clinical Decision Support Enhancements</strong><a class="anchor" aria-label="anchor" href="#id_4-clinical-decision-support-enhancements"></a></h3>
<ul><li>
<strong>Cost-Effectiveness Considerations:</strong> Framework for evaluating staging system implementation costs</li>
</ul><hr></div>
</div>
<div class="section level2">
<h2 id="phase-5-advanced-features-from-claude-stage-migration-analysis"><strong>Phase 5: Advanced Features from Claude Stage Migration Analysis</strong><a class="anchor" aria-label="anchor" href="#phase-5-advanced-features-from-claude-stage-migration-analysis"></a></h2>
<div class="section level3">
<h3 id="id_1-advanced-cox-modeling-enhancements"><strong>1. Advanced Cox Modeling Enhancements</strong><a class="anchor" aria-label="anchor" href="#id_1-advanced-cox-modeling-enhancements"></a></h3>
<ul><li>✅ <strong>Frailty Models for Clustering:</strong> Mixed-effects Cox models (coxme) for multi-institutional data with center-specific random effects (v0.0.3.81)</li>
</ul></div>
<div class="section level3">
<h3 id="id_2-enhanced-stage-migration-quantification"><strong>2. Enhanced Stage Migration Quantification</strong><a class="anchor" aria-label="anchor" href="#id_2-enhanced-stage-migration-quantification"></a></h3>
<ul><li>
<strong>Migration Correction Methods:</strong> Apply probability-weighted expectations to adjust for migration effects</li>
</ul></div>
<div class="section level3">
<h3 id="id_3-regulatory-and-clinical-guidelines-integration"><strong>3. Regulatory and Clinical Guidelines Integration</strong><a class="anchor" aria-label="anchor" href="#id_3-regulatory-and-clinical-guidelines-integration"></a></h3>
<ul><li>
<strong>REMARK Guidelines Adherence:</strong> 20-item checklist for prognostic marker studies</li>
<li>
<strong>TRIPOD Statement Compliance:</strong> 27-item checklist for prediction model development</li>
<li>
<strong>Registry Compatibility Assessment:</strong> Ensure new staging aligns with cancer registry systems</li>
<li>
<strong>Timeline Projection Tools:</strong> Estimate development-validation-implementation timeline (5-7 years)</li>
</ul></div>
<div class="section level3">
<h3 id="id_4-advanced-validation-methodologies"><strong>4. Advanced Validation Methodologies</strong><a class="anchor" aria-label="anchor" href="#id_4-advanced-validation-methodologies"></a></h3>
<ul><li>
<strong>Transportability Assessment:</strong> Evaluate performance across different populations and settings</li>
<li>
<strong>Temporal Validation:</strong> Assess performance on data from different time periods</li>
<li>
<strong>Geographic Validation:</strong> Test staging system across different geographic regions</li>
</ul></div>
<div class="section level3">
<h3 id="id_5-enhanced-discrimination-metrics"><strong>5. Enhanced Discrimination Metrics</strong><a class="anchor" aria-label="anchor" href="#id_5-enhanced-discrimination-metrics"></a></h3>
<ul><li>✅ <strong>Concordance Probability Estimates:</strong> Alternative concordance measures for heavily censored data (v0.0.3.80)</li>
<li>✅ <strong>Win Ratio Analysis:</strong> Composite endpoint analysis for staging comparison (v0.0.3.80)</li>
</ul></div>
<div class="section level3">
<h3 id="id_6-clinical-decision-analysis-integration"><strong>6. Clinical Decision Analysis Integration</strong><a class="anchor" aria-label="anchor" href="#id_6-clinical-decision-analysis-integration"></a></h3>
<ul><li>
<strong>Clinical Utility Index:</strong> Combine sensitivity/specificity with disease prevalence</li>
<li>
<strong>Number Needed to Treat:</strong> Calculate NNT based on staging-guided interventions</li>
</ul></div>
<div class="section level3">
<h3 id="id_7-machine-learning-integration"><strong>7. Machine Learning Integration</strong><a class="anchor" aria-label="anchor" href="#id_7-machine-learning-integration"></a></h3>
<ul><li>
<strong>Deep Learning Survival Models:</strong> Neural network approaches for complex interactions</li>
<li>
<strong>Ensemble Methods:</strong> Combine multiple models for robust predictions</li>
<li>
<strong>Feature Importance Analysis:</strong> SHAP values and permutation importance</li>
<li>
<strong>Cross-Validation for ML:</strong> Proper CV strategies for survival ML models</li>
</ul></div>
<div class="section level3">
<h3 id="id_8-reporting-and-visualization-excellence"><strong>8. Reporting and Visualization Excellence</strong><a class="anchor" aria-label="anchor" href="#id_8-reporting-and-visualization-excellence"></a></h3>
<ul><li>
<strong>CONSORT-Style Flow Diagrams:</strong> Patient flow through staging analysis</li>
<li>
<strong>Calibration Belt Plots:</strong> Advanced calibration visualization with confidence regions</li>
<li>
<strong>Nomogram Generation:</strong> Clinical prediction tools from staging models</li>
<li>
<strong>Interactive Web Reports:</strong> Shiny-based interactive staging comparison dashboards</li>
</ul></div>
<div class="section level3">
<h3 id="id_9-sample-size-and-power-analysis"><strong>9. Sample Size and Power Analysis</strong><a class="anchor" aria-label="anchor" href="#id_9-sample-size-and-power-analysis"></a></h3>
<ul><li>
<strong>Multi-Stage Power Analysis:</strong> Power calculations for hierarchical staging comparisons</li>
<li>
<strong>Simulation-Based Power:</strong> Monte Carlo methods for complex staging scenarios</li>
<li>
<strong>Adaptive Sample Size:</strong> Interim analysis and sample size re-estimation</li>
</ul></div>
<div class="section level3">
<h3 id="id_10-biomarker-integration-framework"><strong>10. Biomarker Integration Framework</strong><a class="anchor" aria-label="anchor" href="#id_10-biomarker-integration-framework"></a></h3>
<ul><li>
<strong>Multi-Marker Panels:</strong> Combine multiple biomarkers with anatomic staging</li>
<li>
<strong>Cost-Effectiveness Analysis:</strong> Evaluate biomarker addition from economic perspective</li>
<li>
<strong>Missing Biomarker Handling:</strong> Multiple imputation for incomplete biomarker data</li>
<li>
<strong>Validation of Biomarker Staging:</strong> Specific validation approaches for integrated staging</li>
</ul><hr></div>
</div>
<div class="section level2">
<h2 id="phase-6-advanced-features-from-gemini-stage-migration-analysis"><strong>Phase 6: Advanced Features from Gemini Stage Migration Analysis</strong><a class="anchor" aria-label="anchor" href="#phase-6-advanced-features-from-gemini-stage-migration-analysis"></a></h2>
<div class="section level3">
<h3 id="id_1-systematic-stage-development-framework"><strong>1. Systematic Stage Development Framework</strong><a class="anchor" aria-label="anchor" href="#id_1-systematic-stage-development-framework"></a></h3>
<ul><li>
<strong>Bootstrap Model/Cutpoint Selection Method:</strong> Systematic search across candidate staging systems using bootstrap-estimated criteria</li>
<li>
<strong>Orderly Progressive Condensation:</strong> Define T and N category groupings with partial ordering constraints</li>
<li>
<strong>Minimum Stage Size Constraints:</strong> Ensure each stage contains ≥5% of sample for statistical stability</li>
<li>
<strong>Eligible System Generation:</strong> Algorithm to generate all valid candidate staging systems adhering to pre-specified rules</li>
</ul></div>
<div class="section level3">
<h3 id="id_2-advanced-multi-cutpoint-optimization"><strong>2. Advanced Multi-cutpoint Optimization</strong><a class="anchor" aria-label="anchor" href="#id_2-advanced-multi-cutpoint-optimization"></a></h3>
<ul><li>
<strong>Simultaneous Optimization:</strong> Multiple cutpoint optimization for complex staging systems</li>
</ul></div>
<div class="section level3">
<h3 id="id_3-model-interpretability-enhancement"><strong>3. Model Interpretability Enhancement</strong><a class="anchor" aria-label="anchor" href="#id_3-model-interpretability-enhancement"></a></h3>
<ul><li>
<strong>SHAP Summary Plots:</strong> Visualize direction and magnitude of feature impacts across dataset</li>
<li>
<strong>SHAP Bar Plots:</strong> Rank features by average absolute SHAP values for importance hierarchy</li>
<li>
<strong>SHAP Dependence Plots:</strong> Reveal non-linear relationships and feature interactions</li>
<li>
<strong>Individual Force Plots:</strong> Patient-specific prediction explanations showing feature contributions</li>
<li>
<strong>Global vs Local Interpretability:</strong> Framework for both population-level and individual-level explanations</li>
</ul></div>
<div class="section level3">
<h3 id="id_4-stage-migration-quantification-tools"><strong>4. Stage Migration Quantification Tools</strong><a class="anchor" aria-label="anchor" href="#id_4-stage-migration-quantification-tools"></a></h3>
<ul><li>
<strong>Immune Response Hypothesis Testing:</strong> Assess if lymph node count reflects immune response vs. understaging</li>
<li>
<strong>Lymph Node Yield Analysis:</strong> Correlate node count with survival independent of positivity</li>
<li>
<strong>Temporal Migration Tracking:</strong> Monitor stage distribution changes over diagnostic eras</li>
<li>
<strong>Multi-Factor Migration Analysis:</strong> Separate effects of diagnostic improvement vs. biological factors</li>
</ul></div>
<div class="section level3">
<h3 id="id_5-clinical-implementation-framework"><strong>5. Clinical Implementation Framework</strong><a class="anchor" aria-label="anchor" href="#id_5-clinical-implementation-framework"></a></h3>
<ul><li>
<strong>Online Platform Deployment:</strong> Web calculator implementation for real-time risk assessment</li>
<li>
<strong>Electronic Health Record Integration:</strong> Embed staging tools within clinical workflows</li>
<li>
<strong>Clinical Workflow Optimization:</strong> Streamline staging assessment at point of care</li>
</ul></div>
<div class="section level3">
<h3 id="id_6-advanced-performance-metrics-implementation"><strong>6. Advanced Performance Metrics Implementation</strong><a class="anchor" aria-label="anchor" href="#id_6-advanced-performance-metrics-implementation"></a></h3>
<ul><li>
<strong>Landmark Analysis Framework:</strong> Convert survival to binary outcomes at clinically relevant timepoints</li>
<li>
<strong>Explained Variation (π̂):</strong> Landmark-based measure of prognostic power</li>
<li>
<strong>Concordance Probability (K̂):</strong> Generalized C-index accounting for all observation pairs</li>
</ul></div>
<div class="section level3">
<h3 id="id_7-r-package-integration-suite"><strong>7. R Package Integration Suite</strong><a class="anchor" aria-label="anchor" href="#id_7-r-package-integration-suite"></a></h3>
<ul><li>
<strong>SurvMetrics Integration:</strong> Enhanced C-index calculations for tied survival data</li>
<li>
<strong>calibmsm for Multistate Models:</strong> Advanced calibration assessment for complex transitions</li>
</ul></div>
<div class="section level3">
<h3 id="id_8-biomarker-and-additional-factor-integration"><strong>8. Biomarker and Additional Factor Integration</strong><a class="anchor" aria-label="anchor" href="#id_8-biomarker-and-additional-factor-integration"></a></h3>
<ul><li>
<strong>Inflammation-Based Biomarkers:</strong> NAR, SII, PNI integration into staging</li>
<li>
<strong>Pathology Grade Integration:</strong> Incorporate tumor differentiation into staging</li>
<li>
<strong>Molecular Alterations:</strong> BRAF mutations, tumor markers (CEA) as staging factors</li>
<li>
<strong>Treatment Response Factors:</strong> Surgery status, adjuvant therapy considerations</li>
<li>
<strong>Comorbidity Adjustment:</strong> Account for patient factors affecting prognosis</li>
</ul></div>
<div class="section level3">
<h3 id="id_9-quality-assurance-and-regulatory-compliance"><strong>9. Quality Assurance and Regulatory Compliance</strong><a class="anchor" aria-label="anchor" href="#id_9-quality-assurance-and-regulatory-compliance"></a></h3>
<ul><li>
<strong>Missing Data Pattern Analysis:</strong> Identify and handle systematic missingness</li>
<li>
<strong>Cancer-Specific Validation:</strong> Tailored approaches for different malignancy types</li>
</ul></div>
<div class="section level3">
<h3 id="id_10-advanced-visualization-suite"><strong>10. Advanced Visualization Suite</strong><a class="anchor" aria-label="anchor" href="#id_10-advanced-visualization-suite"></a></h3>
<ul><li>
<strong>Interactive Dashboard Components:</strong> Dynamic visualizations for exploring results</li>
</ul></div>
<div class="section level3">
<h3 id="id_11-clinical-translation-tools"><strong>11. Clinical Translation Tools</strong><a class="anchor" aria-label="anchor" href="#id_11-clinical-translation-tools"></a></h3>
<ul><li>
<strong>Implementation Timelines:</strong> Project 5-7 year development-validation-adoption cycle</li>
<li>
<strong>Training Module Development:</strong> Educational resources for new staging criteria</li>
<li>
<strong>Performance Monitoring Framework:</strong> Track real-world staging system performance</li>
</ul><hr></div>
</div>
<div class="section level2">
<h2 id="next-priority-features"><strong>Next Priority Features</strong><a class="anchor" aria-label="anchor" href="#next-priority-features"></a></h2>
<p>Based on current implementation status, the next logical features to implement would be:</p>
<ol style="list-style-type: decimal"><li>
<strong>Deep Learning Survival Models</strong> (Phase 5, Section 7) - Neural network approaches for complex interactions and ensemble methods</li>
<li>
<strong>Clinical Utility Index</strong> (Phase 5, Section 6) - Combine sensitivity/specificity with disease prevalence for clinical decision analysis</li>
<li>
<strong>Migration Correction Methods</strong> (Phase 5, Section 2) - Apply probability-weighted expectations to adjust for migration effects</li>
<li>
<strong>Multi-level Staging Creation</strong> (Phase 6, Section 4) - Simultaneous multi-cutpoint optimization for complex staging systems</li>
</ol><p>These represent the most methodologically sound next steps that build upon the existing advanced survival analysis foundation.</p>
</div>
</div>


  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by <a href="https://www.serdarbalci.com/" class="external-link">Serdar Balci</a>.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer></div>





  </body></html>

